Neal D Shore

Neal D Shore

UNVERIFIED PROFILE

Are you Neal D Shore?   Register this Author

Register author
Neal D Shore

Neal D Shore

Publications by authors named "Neal D Shore"

Are you Neal D Shore?   Register this Author

100Publications

3424Reads

30Profile Views

A New Sustained-release, 3-Month Leuprolide Acetate Formulation Achieves and Maintains Castrate Concentrations of Testosterone in Patients With Prostate Cancer.

Clin Ther 2019 03 8;41(3):412-425. Epub 2019 Feb 8.

GP-Pharm S.A., Pol. Industrial Els Vinyets-Els Fogars, St. Quintí de Mediona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2019.01.004DOI Listing
March 2019

Preserving Independent Urology: LUGPA's First Decade.

Rev Urol 2019 ;21(2-3):102-108

Past President and Current Chair, Political Affairs Committee and Advanced Payment Model Task Force, LUGPA; The Urology Group Cincinnati, OH.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864914PMC
January 2019

Recognizing Symptom Burden in Advanced Prostate Cancer: A Global Patient and Caregiver Survey.

Clin Genitourin Cancer 2018 04 5;16(2):e411-e419. Epub 2017 Oct 5.

Carolina Urologic Research Center, Myrtle Beach, SC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.09.015DOI Listing
April 2018

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

J Clin Oncol 2018 02 13;36(4):414-424. Epub 2017 Dec 13.

Veda N. Giri, Karen E. Knudsen, William K. Kelly, Robert B. Den, Adam P. Dicker, Jean Hoffman-Censits, Mark D. Hurwitz, Colette Hyatt, Grace Lu-Yao, Mark J. Mann, James R. Mark, Peter A. McCue, Ronald E. Myers, Stephen C. Peiper, Edouard J. Trabulsi, and Leonard G. Gomella, Jefferson Sidney Kimmel Cancer Center; Justin E. Bekelman, University of Pennsylvania Perelman School of Medicine; S. Bruce Malkowicz, University of Pennsylvania; Elias Obeid and Robert Uzzo, Fox Chase Cancer Center; Gordon F. Schwartz, Foundation for Breast and Prostate Health, Philadelphia; Mark S. Shahin, Hanjani Institute for Gynecologic Oncology, Abington Hospital-Jefferson Health, Abington, PA; Wassim Abida, Philip Kantoff, and Mark E. Robson, Memorial Sloan Kettering Cancer Center; Mitchell C. Benson, Columbia University, New York, NY; Gerald L. Andriole, Washington University School of Medicine, St Louis, MO; Chris H. Bangma, Erasmus Medical Center, Rotterdam, the Netherlands; Amie Blanco, and Matthew Cooperberg, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco; Christopher J. Kane, University of California San Diego, San Diego; Howard Sandler, Cedars-Sinai Medical Center, Los Angeles; Howard R. Soule, Prostate Cancer Foundation, Santa Monica, CA; Arthur Burnett, William B. Isaacs, Christian P. Pavlovich, and Patrick C. Walsh, Johns Hopkins Medical Institutions, Baltimore; Peter A. Pinto and Carol J. Weil, National Cancer Institute, Bethesda, MD; William J. Catalona and Edward Schaeffer, Northwestern University Feinberg School of Medicine; Scott Eggener, Sarah M. Nielsen, and Donald J. Vander Griend, University of Chicago, Chicago, IL; Kathleen A. Cooney, University of Utah School of Medicine, Salt Lake City, UT; David E. Crawford, University of Colorado, Aurora; Lawrence I. Karsh, The Urology Center of Colorado, Denver; Wendy Poage, Prostate Conditions Education Council, Elizabeth, CO; Neil Fleshner, University of Toronto Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Matthew L. Freedman, Kevin R. Loughlin, and Timothy R. Rebbeck, Dana Farber Cancer Institute, and Harvard TH Chan School of Public Health, Boston, MA; Freddie C. Hamdy, University of Oxford, Oxford, England; R. Jeffrey Karnes, Mayo Clinic, Rochester, MN; Eric A. Klein, Cleveland Clinic, Cleveland; Robert Pilarski, The Ohio State University, Columbus, OH; Daniel W. Lin, University of Washington, Seattle, WA; Martin M. Miner, Brown University, Providence, RI; Todd Morgan and Scott A. Tomlins, University of Michigan, Ann Arbor; Matt T. Rosenberg, Mid-Michigan Health Center, Jackson, MI; Judd W. Moul, Duke University, Duke Cancer Institute, Durham, NC; David F. Penson, Vanderbilt University Medical Center, Nashville, TN; Daniel Petrylak and Brian Shuch, Yale University, New Haven, CT; Curtis A. Pettaway, The University of Texas MD Anderson Cancer Center, Houston; Ganesh V. Raj, University of Texas Southwestern Medical Center at Dallas, Dallas, TX; Oliver Sartor, Tulane University Medical School, New Orleans, LA; Neal D. Shore, Atlantic Urology Clinics/Carolina Urologic Research Center, Myrtle Beach, SC; and Richard Wender, American Cancer Society, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.1173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075860PMC
February 2018

LUGPA Onsite and LUGPA Virtual Crossfire Programs Offer Novel Alternatives to Attending an Out-oftown LUGPA Meeting.

Authors:
Neal D Shore

Rev Urol 2018 ;20(1):26-27

President, LUGPA; Atlantic Urology Clinics Myrtle Beach, SC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3909/riu0791DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003300PMC
January 2018

LUGPA Celebrates Its 10th Anniversary at Its 2018 Annual Meeting.

Authors:
Neal D Shore

Rev Urol 2018 ;20(3):131-132

Atlantic Urology Clinics Myrtle Beach, SC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3909/riu0816DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241896PMC
January 2018

Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.

J Clin Oncol 2017 Oct 23;35(30):3410-3416. Epub 2017 Aug 23.

Neal D. Shore, Carolina Urologic Research Center, Myrtle Beach, SC; Stephen A. Boorjian, Mayo Clinic, Rochester, MN; Daniel J. Canter, Ochsner Health System, New Orleans, LA; Kenneth Ogan, Emory University, Atlanta, GA; Lawrence I. Karsh, The Urology Center of Colorado, Denver, CO; Tracy M. Downs, University of Wisconsin, Madison, WI; Leonard G. Gomella, Thomas Jefferson University, Philadelphia, PA; Ashish M. Kamat and Colin P.N. Dinney, University of Texas MD Anderson Cancer Center; Seth P. Lerner, Baylor College of Medicine, Houston; Yair Lotan, University of Texas Southwestern Medical Center, Dallas; Robert S. Svatek, University of Texas Health Science Center at San Antonio, San Antonio, TX; Trinity J. Bivalacqua, Johns Hopkins School of Medicine, Baltimore, MD; Robert L. Grubb III, Washington University, St Louis, MO; Tracey L. Krupski, University of Virginia, Charlottesville, VA; Michael E. Woods and Matthew I. Milowsky, University of North Carolina, Chapel Hill; Brant A. Inman, Duke University, Durham, NC; Alan Boyd, Alan Boyd Consultants, Cottenham; F. Peter Treasure, Peter Treasure Statistical Services, King's Lynn, United Kingdom; Gillian Gregory, David G. Sawutz, and Nigel R. Parker, FKD Therapies Oy; and Seppo Yla-Herttuala, A.I. Virtanen Institute University of Eastern Finland and Science Service Center and Gene Therapy Unit, Kuopio, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.3064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648171PMC
October 2017

Safety and Antitumor Activity of Apalutamide (ARN-509) in Metastatic Castration-Resistant Prostate Cancer with and without Prior Abiraterone Acetate and Prednisone.

Clin Cancer Res 2017 Jul 17;23(14):3544-3551. Epub 2017 Feb 17.

Sidney Kimmel Center for Prostate and Urologic Cancers, Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-2509DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543693PMC
July 2017

Darolutamide (ODM-201) for the treatment of prostate cancer.

Authors:
Neal D Shore

Expert Opin Pharmacother 2017 Jun 24;18(9):945-952. Epub 2017 May 24.

a Carolina Urologic Research Center , Atlantic Urology Clinics , Myrtle Beach , SC , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14656566.2017.1
Publisher Site
http://dx.doi.org/10.1080/14656566.2017.1329820DOI Listing
June 2017

Abiraterone acetate and prednisone in chemotherapy-naïve prostate cancer patients: rationale, evidence and clinical utility.

Ther Adv Med Oncol 2017 May 22;9(5):319-333. Epub 2017 Mar 22.

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834017698644DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424866PMC
May 2017

LUGPA Enhances 2017 Membership Opportunities.

Authors:
Neal D Shore

Rev Urol 2017 ;19(1):44-45

President, LUGPA; Atlantic Urology ClinicsMyrtle Beach, SC.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434835PMC
http://dx.doi.org/10.3909/riu0750DOI Listing
January 2017

LUGPA news.

Authors:
Neal D Shore

Rev Urol 2017 ;19(2):119-121

President, LUGPA; Atlantic Urology ClinicsMyrtle Beach, SC.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610362PMC
http://dx.doi.org/10.3909/riu0761DOI Listing
January 2017

The society of urologic oncology clinical trials consortium: A brief history and overview.

Rev Urol 2017 ;19(2):122-124

Department of Surgical Oncology, Fox Chase Cancer CenterPhiladelphia, PA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610363PMC
http://dx.doi.org/10.3909/riu0760DOI Listing
January 2017

Practice management for urology groups: LUGPA's Guidebook.

Authors:
Neal D Shore

Rev Urol 2017 ;19(3):164-168

President, LUGPA; Atlantic Urology ClinicsMyrtle Beach, SC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3909/riu0774DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737343PMC
January 2017

Alternative payment models.

Rev Urol 2017 ;19(3):198-199

President, LUGPA; Medical Director, CPI, Carolina Urologic Research Center; National Urology Research Director, 21st Century Oncology, Atlantic Urology ClinicsMyrtle Beach, SC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3909/riu193NewsinUroDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737350PMC
January 2017

Are You Developing an ABC: Advanced Bladder Cancer Clinic?

Authors:
Neal D Shore

Rev Urol 2017 ;19(4):246-247

President, LUGPA; Atlantic Urology Clinics Myrtle Beach, SC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3909/riu0777DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811881PMC
January 2017

LUGPA Welcomes Membership of Smaller Practices.

Authors:
Neal D Shore

Rev Urol 2015 ;17(2):86-7

LUGPA Preseident Elect; Atlantic Urology Clinics, Myrtle Beach, SC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3909/riu0672DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857900PMC
May 2016

Extended release, 6-month formulations of leuprolide acetate for the treatment of advanced prostate cancer: achieving testosterone levels below 20 ng/dl.

Expert Opin Drug Metab Toxicol 2015 ;11(9):1465-74

a 1 University of Colorado Cancer Center, University of Colorado Health Sciences Center, Urologic Oncology Department , Mail Stop F710, 1665 N. Ursula Street, Rm 1004, P.O. Box 6510, Aurora, CO 80045, USA +1 720 848 0195 ; +1 720 848 0203 ;

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/17425255.2015.10
Publisher Site
http://dx.doi.org/10.1517/17425255.2015.1073711DOI Listing
May 2016

Highlights in Metastatic Prostate Cancer From the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: Commentary.

Authors:
Neal D Shore

Clin Adv Hematol Oncol 2016 Apr;14(4 Suppl 5):17-9

Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, South Carolina.

View Article

Download full-text PDF

Source
April 2016

When to initiate treatment with radium-223 in patients with metastatic castration-resistant prostate cancer.

Authors:
Neal D Shore

Clin Adv Hematol Oncol 2016 Jan;14(1):26-9

Atlantic Urology Clinics, Myrtle Beach, South Carolina.

View Article

Download full-text PDF

Source
January 2016

Looking ahead to 2017.

Authors:
Neal D Shore

Rev Urol 2016 ;18(4):225

President, LUGPA; Atlantic Urology Clinics Myrtle Beach, SC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3909/riu0736DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260953PMC
January 2016

Advanced prostate cancer in large group practices.

Rev Urol 2016 ;18(4):226-230

President, LUGPA; Atlantic Urology Clinics Myrtle Beach, SC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3909/riu0737DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260954PMC
January 2016

Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies.

J Urol 2015 Dec 18;194(6):1537-47. Epub 2015 Jul 18.

Smilow Cancer Center, Yale University, New Haven, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2015.06.106DOI Listing
December 2015

Optimal timing of sipuleucel-T treatment in metastatic castration-resistant prostate cancer.

Can J Urol 2015 Dec;22(6):8048-55

University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
December 2015

Advances in the understanding of cancer immunotherapy.

Authors:
Neal D Shore

BJU Int 2015 Sep 18;116(3):321-9. Epub 2015 May 18.

Carolina Urologic Research Center/Atlantic Urology Clinics, Myrtle Beach, SC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12692DOI Listing
September 2015

Thriving in the Independent Setting: Highlights From the 2014 LUGPA Annual Meeting.

Authors:
Neal D Shore

Rev Urol 2015 ;17(1):31-2

2014 Program Committee Chair; Atlantic Urology Clinics, Myrtle Beach, SC.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444772PMC
June 2015

Immunotherapy for castration-resistant prostate cancer: Progress and new paradigms.

Urol Oncol 2015 May 7;33(5):245-60. Epub 2015 Jan 7.

Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2014.10.009DOI Listing
May 2015

Radium-223 dichloride for metastatic castration-resistant prostate cancer: the urologist's perspective.

Authors:
Neal D Shore

Urology 2015 Apr 11;85(4):717-24. Epub 2015 Feb 11.

Department of Urology, Carolina Urologic Research Center, Myrtle Beach, SC. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2014.11.031DOI Listing
April 2015

PROSTVAC® targeted immunotherapy candidate for prostate cancer.

Authors:
Neal D Shore

Immunotherapy 2014 ;6(3):235-47

Carolina Urologic Research Center, 823 82nd Parkway, Myrtle Beach, SC 29572, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.13.176DOI Listing
January 2015

Pharmacological inhibition of myostatin and changes in lean body mass and lower extremity muscle size in patients receiving androgen deprivation therapy for prostate cancer.

J Clin Endocrinol Metab 2014 Oct 27;99(10):E1967-75. Epub 2014 Jun 27.

Department of Medical Sciences (D.P.) and Biostatistics (E.R.), Amgen Inc (D.P.), Thousand Oaks, California 91320; Department of Medicine (C.S.H.), University of Washington, and Fred Hutchinson Cancer Research Center, Seattle, Washington 98109; Carolina Urologic Research Center, (N.D.S.), Myrtle Beach, South Carolina 29579; Urological Associates of Lancaster (P.S.), Lancaster, Pennsylvania 17604; and Massachusetts General Hospital Cancer Center (M.R.S.), Boston, Massachusetts 02114.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2014-1271DOI Listing
October 2014

New biomarkers in prostate cancer.

Oncology (Williston Park) 2014 Feb;28(2):135-42

View Article

Download full-text PDF

Source
February 2014

Sequencing therapy in advanced prostate cancer: focus on sipuleucel-T.

Expert Rev Anticancer Ther 2014 Jan;14(1):51-61

Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://search.proquest.com/openview/a3792b8afdb6152d2ddbeabd
Web Search
http://www.tandfonline.com/doi/full/10.1586/14737140.2014.84
Publisher Site
http://dx.doi.org/10.1586/14737140.2014.848065DOI Listing
January 2014

Comparison of tolerability and adverse events following treatment with two GnRH agonists in patients with advanced prostate cancer.

Urol Nurs 2013 Sep-Oct;33(5):236-44, 248

Watson Pharmaceuticals, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
January 2014

The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.

J Urol 2013 Dec 11;190(6):2161-7. Epub 2013 Jun 11.

University of Texas Southwestern Medical Center, Dallas, Texas; Scott and White Healthcare, Temple, Texas; Western Urological Clinic, Salt Lake City, Utah; Carolina Urological Research Center, Myrtle Beach, South Carolina; Cosmetic Surgery Hospital, Brampton, and Oakville Trafalgar Memorial Hospital, Oakville, Ontario, Canada; The Austin Hospital, Melbourne, Victoria, Australia, Urology Associates of Denver, Denver, Colorado; Atlantic Urological Associates, Daytona Beach, and Pinellas Urology, St. Petersburg, Florida; Northwestern University and Southern Illinois University, Springfield, Illinois; Weill Cornell Medical Center, New York, New York; Urology Associates of Silicon Valley, San Jose, and SD Uro-Research, San Diego, California; Port Macquarie Hospital, Port Macquarie, and Figtree Private Hospital, Figtree, New South Wales, Australia; Chesapeake Urology, Baltimore, Maryland; Freedman, MD, LTD, Las Vegas, Nevada; Geisinger Medical Center and Wake Forest University, Winston-Salem, North Carolina. Electronic address:

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S002253471304597
Publisher Site
http://dx.doi.org/10.1016/j.juro.2013.05.116DOI Listing
December 2013

Infusion therapy and implantables for the urologist.

Urol Clin North Am 2013 Nov;40(4):591-8

Department of Urology, University of California at Davis Medical Center, 4806 Y Street, Suite 2200, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2013.07.014DOI Listing
November 2013

A urologic oncology roundtable discussion: how to choose among the available therapies for the treatment of castration-resistant prostate cancer.

Postgrad Med 2013 Nov;125(6):114-6

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3810/pgm.2013.11.2718DOI Listing
November 2013

The success of therapies for metastatic CRPC continues.

Authors:
Neal D Shore

Oncology (Williston Park) 2013 Nov;27(11):1160-1

Carolina Urologic Research Center, Myrtle Beach, South Carolina, USA.

View Article

Download full-text PDF

Source
November 2013

Experience with degarelix in the treatment of prostate cancer.

Authors:
Neal D Shore

Ther Adv Urol 2013 Feb;5(1):11-24

Atlantic Urology Clinics, 823 82nd Parkway, Myrtle Beach, SC 29572, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756287212461048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547532PMC
February 2013

LHRH Agonists for the Treatment of Prostate Cancer: 2012.

Rev Urol 2012 ;14(1-2):1-12

New York University School of Medicine New York, NY.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503273PMC
January 2013